Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse. - Wikidata - wikimedia - TriplyDB

Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse.

Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse.

http://www.wikidata.org/entity/Q37412503

about

Potential drug targets and treatment of schizophrenia.Adolescent Traumatic Brain Injury Induces Chronic Mesolimbic Neuroinflammation with Concurrent Enhancement in the Rewarding Effects of Cocaine in Mice during Adulthood.

P2860

Q39206300-52BD9D8E-48EF-4C24-B882-38A435103F2C Q39879537-E9E4564F-D169-47CB-BA86-89E003C758E8

P2860

Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse.

http://www.wikidata.org/entity/Q37412503

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse.

@en

Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse.

@nl

type

label

Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse.

@en

Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse.

@nl

prefLabel

Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse.

@en

Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse.

@nl

P1433

Q37412503-15C8EACE-B1ED-4E32-A0B1-2F21105A22CE

P1476

Q37412503-C940C0B3-D6BE-49C2-A66B-B3FF89B034E5

P2093

Q37412503-C784AAF8-D1B5-4939-A5AB-C60B1E7FF631

P2860

Q37412503-016BA769-1B49-49E0-A9C9-D910C157D120

Q37412503-085589D8-9FEB-4314-9698-A3479000F4B2

Q37412503-08E907C7-EE44-489C-97B0-ABB2CF0D784A

Q37412503-0ACB6E18-3E96-4973-B065-A68261583C8B

Q37412503-0F168188-9A85-4D31-BF74-005C623A7E31

Q37412503-1466B383-7C0B-4915-9227-5C86FDB17A3D

Q37412503-1E2CF1FE-A461-4DB6-97C1-20B92AC9C0BD

Q37412503-1F705FA8-2C7A-445C-B88C-33BBC9A196AE

Q37412503-1FD759D3-2FB1-4CCE-9490-E56C254B89BE

Q37412503-24B86136-BBE8-4211-870C-081CAD6B5B80

P304

Q37412503-B7209534-0017-4080-A66E-9BA58A17A191

P31

Q37412503-72B96C56-1110-49F1-BBDB-6EA84CB91CB2

P356

Q37412503-A2CF6D10-3D1D-4750-A438-23028BE3558B

P478

Q37412503-57349833-626A-49E1-8021-C31AD1A0A1AE

P577

Q37412503-66A4AAD6-B8BC-4C07-9879-4A3D7A03B171

P5875

Q37412503-3AAB51C3-7A7C-4089-98B2-791BED04FD8D

P698

Q37412503-C1D012A7-2717-4C48-9D60-1052272E4AF4

P921

Q37412503-563D1EAC-F0C6-48B5-8515-5439EC05C269

P932

Q37412503-10713A4C-7A54-482C-BA0F-D4F0C470D3A3

P356

1874354400903010001

P1433

The open psychiatry journal

P1476

Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse.

@en

P2093

Berit Kerner

http://www.w3.org/2001/XMLSchema#string

P2860

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

Synaptic plasticity and addiction

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis

Glutamatergic substrates of drug addiction and alcoholism

Identification of a serotonin/glutamate receptor complex implicated in psychosis

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

A twin study of genetic relationships between psychotic symptoms

Homeostatic plasticity in the developing nervous system

Synaptic plasticity: multiple forms, functions, and mechanisms

P304

1-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1874354400903010001

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38075592

http://www.w3.org/2001/XMLSchema#string

P698

19898680

http://www.w3.org/2001/XMLSchema#string

P921

P932

2773545

http://www.w3.org/2001/XMLSchema#string